BRCA1 gene expression signature predicts for anthracycline-chemosensitivity in triple-negative breast cancer.

被引：0
|
作者：
Rodriguez, A. A.
Makris, A.
Harrison, M. K.
Ostler, P. J.
Froehlich, A.
Pavlick, A.
Wong, H.
Tsimelzon, A.
Sexton, K.
Hilsenbeck, S. G.
Lewis, M. T.
Rimawi, M.
Osborne, C. K.
Chang, J. C.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Mt Vernon Hosp, Middlesex, England
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358S / 358S
页数：1
相关论文
共 50 条
  • [31] Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
    Kim, Min Chong
    Choi, Jung Eun
    Lee, Soo Jung
    Bae, Young Kyung
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3524 - 3530
  • [32] Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer.
    Lonning, Per Eystein
    Nikolaienko, Oleksii
    Pan, Kathy
    Kurian, Allison W.
    Eikesdal, Hans Petter Petter
    Pettinger, Mary
    Anderson, Garnet L.
    Prentice, Ross L.
    Chlebowski, Rowan T.
    Knappskog, Stian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer
    Ning, Lvwen
    Xie, Ni
    [J]. CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 137 - 150
  • [34] BRCA1 Expression in Triple Negative Sporadic Breast Cancers
    Galizia, Eva
    Giorgetti, Gessica
    Piccinini, Gina
    Santinelli, Alfredo
    Loretelli, Cristian
    Bianchi, Francesca
    Gagliardini, Daniela
    Carbonari, Giovanna
    Pisa, Eleonora
    Belvederesi, Laura
    Bracci, Raffaella
    Ferretti, Concetta
    Corradini, Fabio
    Cellerino, Riccardo
    [J]. ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2010, 32 (01): : 24 - 29
  • [35] Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
    Pan, Jia-Wern
    Tan, Zi-Ching
    Ng, Pei-Sze
    Zabidi, Muhammad Mamduh Ahmad
    Fatin, Putri Nur
    Teo, Jie-Ying
    Hasan, Siti Norhidayu
    Islam, Tania
    Teoh, Li-Ying
    Jamaris, Suniza
    See, Mee-Hoong
    Yip, Cheng-Har
    Rajadurai, Pathmanathan
    Looi, Lai-Meng
    Taib, Nur Aishah Mohd
    Rueda, Oscar M.
    Caldas, Carlos
    Chin, Suet-Feung
    Lim, Joanna
    Teo, Soo-Hwang
    [J]. NPJ BREAST CANCER, 2024, 10 (01)
  • [36] Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women
    E. Comen
    M. Davids
    T. Kirchhoff
    C. Hudis
    K. Offit
    M. Robson
    [J]. Breast Cancer Research and Treatment, 2011, 129 : 185 - 190
  • [37] A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
    Kitahara, Miyuki
    Hozumi, Yasuo
    Machinaga, Mitsuki
    Hayashi, Yuka
    [J]. CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1645 - 1651
  • [38] Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women
    Comen, E.
    Davids, M.
    Kirchhoff, T.
    Hudis, C.
    Offit, K.
    Robson, M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 185 - 190
  • [39] Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer
    Gardi, Nilesh
    Chaubal, Rohan
    Parab, Pallavi
    Pachakar, Sunil
    Kulkarni, Suyash
    Shet, Tanuja
    Joshi, Shalaka
    Kembhavi, Yogesh
    Chandrani, Pratik
    Quist, Jelmar
    Kowtal, Pradnya
    Grigoriadis, Anita
    Sarin, Rajiv
    Govindarajan, Raman
    Gupta, Sudeep
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 404 - 417
  • [40] Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)
    Andres, R.
    Pajares, I.
    Balmana, J.
    Llort, G.
    Ramon y Cajal, T.
    Chirivella, I.
    Aguirre, E.
    Robles, L.
    Lastra, E.
    Perez-Segura, P.
    Bosch, N.
    Yaguee, C.
    Lerma, E.
    Godino, J.
    Miramar, M. D.
    Moros, M.
    Astier, P.
    Saez, B.
    Vidal, M. J.
    Arcusa, A.
    Ramon y Cajal, S.
    Calvo, M. T.
    Tres, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (03): : 280 - 284
12345